162 related articles for article (PubMed ID: 33135461)
1. Estetrol prevents Western diet-induced obesity and atheroma independently of hepatic estrogen receptor α.
Buscato M; Davezac M; Zahreddine R; Adlanmerini M; Métivier R; Fillet M; Cobraiville G; Moro C; Foidart JM; Lenfant F; Gourdy P; Arnal JF; Fontaine C
Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E19-E29. PubMed ID: 33135461
[TBL] [Abstract][Full Text] [Related]
2. Effect of estetrol, a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis.
Valéra MC; Noirrit-Esclassan E; Dupuis M; Fontaine C; Lenfant F; Briaux A; Cabou C; Garcia C; Lairez O; Foidart JM; Payrastre B; Arnal JF
Mol Cell Endocrinol; 2018 Dec; 477():132-139. PubMed ID: 29928930
[TBL] [Abstract][Full Text] [Related]
3. The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation.
Abot A; Fontaine C; Buscato M; Solinhac R; Flouriot G; Fabre A; Drougard A; Rajan S; Laine M; Milon A; Muller I; Henrion D; Adlanmerini M; Valéra MC; Gompel A; Gerard C; Péqueux C; Mestdagt M; Raymond-Letron I; Knauf C; Ferriere F; Valet P; Gourdy P; Katzenellenbogen BS; Katzenellenbogen JA; Lenfant F; Greene GL; Foidart JM; Arnal JF
EMBO Mol Med; 2014 Oct; 6(10):1328-46. PubMed ID: 25214462
[TBL] [Abstract][Full Text] [Related]
4. Predominant Role of Nuclear Versus Membrane Estrogen Receptor α in Arterial Protection: Implications for Estrogen Receptor α Modulation in Cardiovascular Prevention/Safety.
Guivarc'h E; Buscato M; Guihot AL; Favre J; Vessières E; Grimaud L; Wakim J; Melhem NJ; Zahreddine R; Adlanmerini M; Loufrani L; Knauf C; Katzenellenbogen JA; Katzenellenbogen BS; Foidart JM; Gourdy P; Lenfant F; Arnal JF; Henrion D; Fontaine C
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29959137
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte estrogen receptor alpha mediates estrogen action to promote reverse cholesterol transport during Western-type diet feeding.
Zhu L; Shi J; Luu TN; Neuman JC; Trefts E; Yu S; Palmisano BT; Wasserman DH; Linton MF; Stafford JM
Mol Metab; 2018 Feb; 8():106-116. PubMed ID: 29331506
[TBL] [Abstract][Full Text] [Related]
6. Hormone signaling and fatty liver in females: analysis of estrogen receptor α mutant mice.
Hart-Unger S; Arao Y; Hamilton KJ; Lierz SL; Malarkey DE; Hewitt SC; Freemark M; Korach KS
Int J Obes (Lond); 2017 Jun; 41(6):945-954. PubMed ID: 28220039
[TBL] [Abstract][Full Text] [Related]
7. Estetrol, a Fetal Selective Estrogen Receptor Modulator, Acts on the Vagina of Mice through Nuclear Estrogen Receptor α Activation.
Benoit T; Valera MC; Fontaine C; Buscato M; Lenfant F; Raymond-Letron I; Tremollieres F; Soulie M; Foidart JM; Game X; Arnal JF
Am J Pathol; 2017 Nov; 187(11):2499-2507. PubMed ID: 28827141
[TBL] [Abstract][Full Text] [Related]
8. Selective Activation of Estrogen Receptor α Activation Function-1 Is Sufficient to Prevent Obesity, Steatosis, and Insulin Resistance in Mouse.
Guillaume M; Handgraaf S; Fabre A; Raymond-Letron I; Riant E; Montagner A; Vinel A; Buscato M; Smirnova N; Fontaine C; Guillou H; Arnal JF; Gourdy P
Am J Pathol; 2017 Jun; 187(6):1273-1287. PubMed ID: 28502695
[TBL] [Abstract][Full Text] [Related]
9. Clinical effects of the fetal estrogen estetrol in a multiple-rising-dose study in postmenopausal women.
Coelingh Bennink HJ; Verhoeven C; Zimmerman Y; Visser M; Foidart JM; Gemzell-Danielsson K
Maturitas; 2016 Sep; 91():93-100. PubMed ID: 27451327
[TBL] [Abstract][Full Text] [Related]
10. Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract.
Barrera J; Chambliss KL; Ahmed M; Tanigaki K; Thompson B; McDonald JG; Mineo C; Shaul PW
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E345-54. PubMed ID: 24939737
[TBL] [Abstract][Full Text] [Related]
11.
Herrera-Marcos LV; Sancho-Knapik S; Gabás-Rivera C; Barranquero C; Gascón S; Romanos E; Martínez-Beamonte R; Navarro MA; Surra JC; Arnal C; García-de-Jalón JA; Rodríguez-Yoldi MJ; Tena-Sempere M; Sánchez-Ramos C; Monsalve M; Osada J
Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E249-E261. PubMed ID: 31846369
[TBL] [Abstract][Full Text] [Related]
12. Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause.
Gérard C; Arnal JF; Jost M; Douxfils J; Lenfant F; Fontaine C; Houtman R; Archer DF; Reid RL; Lobo RA; Gaspard U; Coelingh Bennink HJT; Creinin MD; Foidart JM
Expert Rev Clin Pharmacol; 2022 Feb; 15(2):121-137. PubMed ID: 35306927
[TBL] [Abstract][Full Text] [Related]
13. Estetrol is a weak estrogen antagonizing estradiol-dependent mammary gland proliferation.
Gérard C; Blacher S; Communal L; Courtin A; Tskitishvili E; Mestdagt M; Munaut C; Noel A; Gompel A; Péqueux C; Foidart JM
J Endocrinol; 2015 Jan; 224(1):85-95. PubMed ID: 25359896
[TBL] [Abstract][Full Text] [Related]
14. Disocin prevents postmenopausal atherosclerosis in ovariectomized LDLR-/- mice through a PGC-1α/ERα pathway leading to promotion of autophagy and inhibition of oxidative stress, inflammation and apoptosis.
Yang Q; Wang C; Jin Y; Ma X; Xie T; Wang J; Liu K; Sun H
Pharmacol Res; 2019 Oct; 148():104414. PubMed ID: 31449974
[TBL] [Abstract][Full Text] [Related]
15. Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptoms.
Gérard C; Mestdagt M; Tskitishvili E; Communal L; Gompel A; Silva E; Arnal JF; Lenfant F; Noel A; Foidart JM; Péqueux C
Oncotarget; 2015 Jul; 6(19):17621-36. PubMed ID: 26056044
[TBL] [Abstract][Full Text] [Related]
16. Effect of estetrol administration on brain and serum allopregnanolone in intact and ovariectomized rats.
Pluchino N; Santoro AN; Casarosa E; Giannini A; Genazzani A; Russo M; Russo N; Petignat P; Genazzani AR
J Steroid Biochem Mol Biol; 2014 Sep; 143():285-90. PubMed ID: 24787659
[TBL] [Abstract][Full Text] [Related]
17. Activation of estrogen receptor α (ERα) is required for Alisol B23-acetate to prevent post-menopausal atherosclerosis and reduced lipid accumulation.
Chen Q; Chao Y; Zhang W; Zhang Y; Bi Y; Fu Y; Cai D; Meng Q; Li Y; Bian H
Life Sci; 2020 Oct; 258():118030. PubMed ID: 32739470
[TBL] [Abstract][Full Text] [Related]
18. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
Nuotio-Antar AM; Hachey DL; Hasty AH
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1517-28. PubMed ID: 17878220
[TBL] [Abstract][Full Text] [Related]
19. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
Coenen KR; Hasty AH
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116
[TBL] [Abstract][Full Text] [Related]
20. Liver-selective γ-secretase inhibition ameliorates diet-induced hepatic steatosis, dyslipidemia and atherosclerosis.
Kim K; Yu J; Kang JK; Morrow JP; Pajvani UB
Biochem Biophys Res Commun; 2020 Jul; 527(4):979-984. PubMed ID: 32439159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
